Dawson James Starts Apricus Biosciences (APRI) at Buy; Busy and Productive
Tweet Send to a Friend
Dawson James initiates coverage on Apricus Biosciences (NASDAQ: APRI) with a Buy. PT $5.50.
Dawson analyst says, "Apricus Bio has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Dawson analyst says, "Apricus Bio has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
